Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome

Citation
Nc. Mcdermott et al., Immunohistochemical expression of nm23 in primary invasive malignant melanoma is predictive of survival outcome, J PATHOLOGY, 190(2), 2000, pp. 157-162
Citations number
30
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF PATHOLOGY
ISSN journal
00223417 → ACNP
Volume
190
Issue
2
Year of publication
2000
Pages
157 - 162
Database
ISI
SICI code
0022-3417(200002)190:2<157:IEONIP>2.0.ZU;2-B
Abstract
The objective of this study was to determine the utility of nm23 as an immu nohistochemical indicator of prognosis in a large series (157 cases) of mal ignant melanoma and also in two subsets within this group: stage 1 tumours, whether in radial or vertical growth phase (140 cases); and stage 1 tumour s in which a vertical growth phase component was positively identified (123 cases). A secondary objective was to explore the relationship between the immunohistochemical expression of nm23 and established clinical and histolo gical indicators of prognosis in each of these three groups. In all groups it was found that strong immunoreactivity correlated positively with surviv al and inversely with indicators of poor prognosis, in keeping with transfe ction and mRNA studies and also with many immunohistochemical studies of ot her tumour types. That these findings are at variance with earlier reported immunohistochemical studies of melanoma highlights the importance of large case numbers of primary invasive tumours in studies which set out to explo re the relationship between immunoreactivity and survival. Copyright (C) 20 00 John Wiley & Sons, Ltd.